Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amylx Pharmaceuticals Inc (AMLX) vs Orion Office REIT Inc (ONL) Price & Performance

Amylx Pharmaceuticals IncTrade
Orion Office REIT IncTrade

Price performance (Past 24H)

Key statistics

Amylx Pharmaceuticals Inc vs Orion Office REIT Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Orion Office REIT Inc trades at $2.72 (market cap $158.01M). The key difference: Amylx Pharmaceuticals Inc is far larger — about 16.7× Orion Office REIT Inc's market cap, and Orion Office REIT Inc pays a 2.89% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

AMLXONL
Market Cap
$2.64B$158.01M
Sector
HealthReal Estate
52-Week High
$24.19$3.04
52-Week Low
$7.82$1.93
Enterprise Value
$2.39B$574.95M
Dividend Yield
2.89%

Returns comparison

Trailing returns across standard periods

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.

Read more on AMLX

About Orion Office REIT Inc

Orion Office REIT Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased primarily on a single-tenant net lease basis to creditworthy clients.

Read more on ONL